Skip to main content
Top
Published in: The International Journal of Cardiovascular Imaging 4/2013

Open Access 01-04-2013 | Original Paper

Standard and feature tracking magnetic resonance evidence of myocardial involvement in Churg–Strauss syndrome and granulomatosis with polyangiitis (Wegener’s) in patients with normal electrocardiograms and transthoracic echocardiography

Authors: Tomasz Miszalski-Jamka, Wojciech Szczeklik, Barbara Sokołowska, Krzysztof Karwat, Katarzyna Belzak, Wojciech Mazur, Dean J. Kereiakes, Jacek Musiał

Published in: The International Journal of Cardiovascular Imaging | Issue 4/2013

Login to get access

Abstract

The aim of the study was to evaluate the presence and spectrum of cardiac abnormalities identified by cardiac magnetic resonance (CMR) in subjects in clinical remission of Churg–Strauss syndrome (CSS) and granulomatosis with polyangiitis (Wegener’s) (WG) with normal ECG and transthoracic echocardiography (TTE). Eleven (7 females, 4 males, mean age 42.4 ± 9.6 years) CSS and 10 (4 females, 6 males, mean age 45.3 ± 10.9 years) WG patients in clinical remission with normal ECG and TTE underwent CMR. Segmental peak-systolic myocardial strain (εps) was measured using feature tracking cine-sequence based technique. Left ventricular (LV) ejection fraction, end-diastolic volume and myocardial mass indexes were 66.2 ± 5.8 %, 66.1 ± 6.6 ml/m2, and 61.0 ± 8.9 g/m2, respectively. No patient showed regional wall motion abnormalities and signs of myocarditis. Nine CSS and 8 WG patients demonstrated decreased segmental longitudinal, circumferential or radial εps and myocardial late gadolinium enhancement (LGE) (6 subendocardial, 10 midwall, 8 subepicardial) areas. In CSS and WG subjects with LVLGE lesions the mean LVLGE extent was 2.0 ± 1.6 % and 2.3 ± 1.5 % (p = 0.65), respectively. Segmental εps was decreased longitudinally (−11.8 ± 5.6 %) for subendocardial LGE, radially (13.7 ± 8.7 %) for subepicardial LGE, and circumferentially (−16.6 ± 4.2 %), longitudinally (−13.2 ± 5.5 %) and radially (18.8 ± 8.1 %) for midwall LGE, if compared to longitudinal (−22.7 ± 5.1 %), circumferential (−23.6 ± 5.6 %) and radial (34.2 ± 15.7 %) εps in controls (11 females, 10 males, mean age 43.9 ± 10.5 years) (all p < 0.01). Despite clinical remission, normal ECG and TTE, most CSS and WG patients demonstrate decreased segmental εps and non-ischemic LGE lesions without signs of myocarditis.
Literature
1.
go back to reference Knockaert DC (2007) Cardiac involvement in systemic inflammatory diseases. Eur Heart J 28:1797–1804PubMedCrossRef Knockaert DC (2007) Cardiac involvement in systemic inflammatory diseases. Eur Heart J 28:1797–1804PubMedCrossRef
2.
go back to reference Kane GC, Keogh KA (2009) Involvement of the heart by small and medium vessel vasculitis. Curr Opin Rheumatol 21:29–34PubMedCrossRef Kane GC, Keogh KA (2009) Involvement of the heart by small and medium vessel vasculitis. Curr Opin Rheumatol 21:29–34PubMedCrossRef
3.
go back to reference Hor KN, Gottliebson WM, Carson C, Wash E, Cnota J, Fleck R, Wansapura J, Klimeczek P, Al-Khalidi HR, Chung ES, Benson DW, Mazur W (2010) Comparison of magnetic resonance feature tracking for strain calculation with harmonic phase imaging analysis. JACC Cardiovasc Imag 3:144–151CrossRef Hor KN, Gottliebson WM, Carson C, Wash E, Cnota J, Fleck R, Wansapura J, Klimeczek P, Al-Khalidi HR, Chung ES, Benson DW, Mazur W (2010) Comparison of magnetic resonance feature tracking for strain calculation with harmonic phase imaging analysis. JACC Cardiovasc Imag 3:144–151CrossRef
4.
go back to reference Hor KN, Wansapura J, Markham LW, Mazur W, Cripe LH, Fleck R, Benson DW, Gottliebson WM (2009) Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study. J Am Coll Cardiol 53:1204–1210PubMedCrossRef Hor KN, Wansapura J, Markham LW, Mazur W, Cripe LH, Fleck R, Benson DW, Gottliebson WM (2009) Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study. J Am Coll Cardiol 53:1204–1210PubMedCrossRef
5.
go back to reference Miszalski-Jamka T, Szczeklik W, Nycz K, Sokołowska B, Górka J, Bury K, Musiał J (2012) Two-dimensional speckle-tracking echocardiography reveals systolic abnormalities in granulomatosis with polyangiitis (Wegener’s). Echocardiography 29:803–809PubMedCrossRef Miszalski-Jamka T, Szczeklik W, Nycz K, Sokołowska B, Górka J, Bury K, Musiał J (2012) Two-dimensional speckle-tracking echocardiography reveals systolic abnormalities in granulomatosis with polyangiitis (Wegener’s). Echocardiography 29:803–809PubMedCrossRef
6.
go back to reference Miszalski-Jamka T, Szczeklik W, Nycz K, Sokołowska B, Bury K, Zawadowski G, Noelting J, Mazur W, Musiał J (2012) The mechanics of left ventricular dysfunction in patients with Churg–Strauss syndrome. Echocardiography 29:568–578PubMedCrossRef Miszalski-Jamka T, Szczeklik W, Nycz K, Sokołowska B, Bury K, Zawadowski G, Noelting J, Mazur W, Musiał J (2012) The mechanics of left ventricular dysfunction in patients with Churg–Strauss syndrome. Echocardiography 29:568–578PubMedCrossRef
7.
go back to reference Dennert RM, van Paassen P, Schalla S, Kuznetsova T, Alzand BS, Staessen JA, Velthuis S, Crijns HJ, Tervaert JW, Heymans S (2010) Cardiac involvement in Churg–Strauss syndrome. Arthr Rheum 62:627–634 Dennert RM, van Paassen P, Schalla S, Kuznetsova T, Alzand BS, Staessen JA, Velthuis S, Crijns HJ, Tervaert JW, Heymans S (2010) Cardiac involvement in Churg–Strauss syndrome. Arthr Rheum 62:627–634
8.
go back to reference Miszalski-Jamka T, Szczeklik W, Sokołowska B, Miszalski-Jamka K, Karwat K, Grządziel G, Mazur W, Kereiakes DJ, Musiał J (2011) Cardiac involvement in Wegener’s granulomatosis resistant to induction therapy. Eur Radiol 21:2297–2304PubMedCrossRef Miszalski-Jamka T, Szczeklik W, Sokołowska B, Miszalski-Jamka K, Karwat K, Grządziel G, Mazur W, Kereiakes DJ, Musiał J (2011) Cardiac involvement in Wegener’s granulomatosis resistant to induction therapy. Eur Radiol 21:2297–2304PubMedCrossRef
9.
go back to reference Wassmuth R, Göbel U, Natusch A, Schneider W, Kettritz R, Dietz R, Luft FC, Schulz-Menger J (2008) Cardiovascular magnetic resonance imaging detects cardiac involvement in Churg–Strauss syndrome. J Card Fail 14:856–860PubMedCrossRef Wassmuth R, Göbel U, Natusch A, Schneider W, Kettritz R, Dietz R, Luft FC, Schulz-Menger J (2008) Cardiovascular magnetic resonance imaging detects cardiac involvement in Churg–Strauss syndrome. J Card Fail 14:856–860PubMedCrossRef
10.
go back to reference Mavrogeni S, Manoussakis MN, Karagiorga TC, Douskou M, Panagiotakos D, Bournia V, Cokkinos DV, Moutsopoulos HM (2009) Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides. Arthr Rheum 61:1121–1129CrossRef Mavrogeni S, Manoussakis MN, Karagiorga TC, Douskou M, Panagiotakos D, Bournia V, Cokkinos DV, Moutsopoulos HM (2009) Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides. Arthr Rheum 61:1121–1129CrossRef
11.
go back to reference Neumann T, Manger B, Schmid M, Kroegel C, Hansch A, Kaiser WA, Reinhardt D, Wolf G, Hein G, Mall G, Schett G, Zwerina J (2009) Cardiac involvement in Churg–Strauss syndrome: impact of endomyocarditis. Medicine 88:236–243PubMedCrossRef Neumann T, Manger B, Schmid M, Kroegel C, Hansch A, Kaiser WA, Reinhardt D, Wolf G, Hein G, Mall G, Schett G, Zwerina J (2009) Cardiac involvement in Churg–Strauss syndrome: impact of endomyocarditis. Medicine 88:236–243PubMedCrossRef
12.
go back to reference Szczeklik W, Miszalski-Jamka T, Mastalerz L, Sokolowska B, Dropinski J, Banys R, Hor KN, Mazur W, Musial J (2011) Multimodality assessment of cardiac involvement in Churg–Strauss syndrome patients in clinical remission. Circ J 75:649–655PubMedCrossRef Szczeklik W, Miszalski-Jamka T, Mastalerz L, Sokolowska B, Dropinski J, Banys R, Hor KN, Mazur W, Musial J (2011) Multimodality assessment of cardiac involvement in Churg–Strauss syndrome patients in clinical remission. Circ J 75:649–655PubMedCrossRef
13.
go back to reference Szczeklik W, Sokolowska B, Mastalerz L, Miszalski-Jamka T, Musial J (2010) Heart involvement detected by magnetic resonance in a patient with Churg–Strauss syndrome, mimicking severe asthma exacerbation. Allergy 65:1063–1064PubMedCrossRef Szczeklik W, Sokolowska B, Mastalerz L, Miszalski-Jamka T, Musial J (2010) Heart involvement detected by magnetic resonance in a patient with Churg–Strauss syndrome, mimicking severe asthma exacerbation. Allergy 65:1063–1064PubMedCrossRef
14.
go back to reference Caudron J, Fares J, Dominique S, Dacher JN (2009) Diagnosis and follow-up of Wegener’s granulomatosis by cardiac magnetic resonance. Eur Heart J 30:1537PubMedCrossRef Caudron J, Fares J, Dominique S, Dacher JN (2009) Diagnosis and follow-up of Wegener’s granulomatosis by cardiac magnetic resonance. Eur Heart J 30:1537PubMedCrossRef
15.
go back to reference To A, De Zoysa J, Christiansen JP (2007) Cardiomyopathy associated with Wegener’s granulomatosis. Heart 93:984PubMedCrossRef To A, De Zoysa J, Christiansen JP (2007) Cardiomyopathy associated with Wegener’s granulomatosis. Heart 93:984PubMedCrossRef
16.
go back to reference Hansch A, Pfeil A, Rzanny R, Neumann T, Kaiser WA (2009) First-pass myocardial perfusion abnormalities in Churg–Strauss syndrome with cardiac involvement. Int J Cardiovasc Imag 25:501–510CrossRef Hansch A, Pfeil A, Rzanny R, Neumann T, Kaiser WA (2009) First-pass myocardial perfusion abnormalities in Churg–Strauss syndrome with cardiac involvement. Int J Cardiovasc Imag 25:501–510CrossRef
17.
go back to reference Pfeil A, Lehmann G, Böttcher J, Wolf G, Hansch A (2012) The role of first-pass perfusion deficit in the detection of cardiac subendocardial manifestation in patients with autoimmune vasculitis. Rheumatol Int. doi:10.1007/s00296-011-2310-3 PubMed Pfeil A, Lehmann G, Böttcher J, Wolf G, Hansch A (2012) The role of first-pass perfusion deficit in the detection of cardiac subendocardial manifestation in patients with autoimmune vasculitis. Rheumatol Int. doi:10.​1007/​s00296-011-2310-3 PubMed
18.
go back to reference Cocco G, Gasparyan AY (2010) Myocardial ischemia in Wegener’s granulomatosis: coronary atherosclerosis versus vasculitis. Open Cardiovasc Med J 4:57–62PubMed Cocco G, Gasparyan AY (2010) Myocardial ischemia in Wegener’s granulomatosis: coronary atherosclerosis versus vasculitis. Open Cardiovasc Med J 4:57–62PubMed
19.
go back to reference Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lightfoot RW Jr, McShane DJ, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ (1990) The American College of Rheumatology 1990 criteria for the classification of Churg–Strauss syndrome (allergic granulomatosis and angiitis). Arthr Rheum 33:1094–1100CrossRef Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lightfoot RW Jr, McShane DJ, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ (1990) The American College of Rheumatology 1990 criteria for the classification of Churg–Strauss syndrome (allergic granulomatosis and angiitis). Arthr Rheum 33:1094–1100CrossRef
20.
go back to reference Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfoot RW Jr (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthr Rheum 33:1101–1107CrossRef Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfoot RW Jr (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthr Rheum 33:1101–1107CrossRef
21.
go back to reference Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, Flossmann O, Hall C, Hollywood J, Jayne D, Jones R, Lanyon P, Muir A, Scott D, Young L, Luqmani RA (2009) Modification and validation of the Birmingham vasculitis activity score (version 3). Ann Rheum Dis 68:1827–1832PubMedCrossRef Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, Flossmann O, Hall C, Hollywood J, Jayne D, Jones R, Lanyon P, Muir A, Scott D, Young L, Luqmani RA (2009) Modification and validation of the Birmingham vasculitis activity score (version 3). Ann Rheum Dis 68:1827–1832PubMedCrossRef
22.
go back to reference Stone JH, Hoffman GS, Merkel PA, Min YI, Uhlfelder ML, Hellmann DB, Specks U, Allen NB, Davis JC, Spiera RF, Calabrese LH, Wigley FM, Maiden N, Valente RM, Niles JL, Fye KH, McCune JW, St Clair EW, Luqmani RA (2001) A disease-specific activity index for Wegener’s granulomatosis: modification of the Birmingham vasculitis activity score. Arthr Rheum 44:912–920CrossRef Stone JH, Hoffman GS, Merkel PA, Min YI, Uhlfelder ML, Hellmann DB, Specks U, Allen NB, Davis JC, Spiera RF, Calabrese LH, Wigley FM, Maiden N, Valente RM, Niles JL, Fye KH, McCune JW, St Clair EW, Luqmani RA (2001) A disease-specific activity index for Wegener’s granulomatosis: modification of the Birmingham vasculitis activity score. Arthr Rheum 44:912–920CrossRef
23.
go back to reference de Groot K, Gross WL, Herlyn K, Reinhold-Keller E (2001) Development and validation of a disease extent index for Wegener’s granulomatosis. Clin Nephrol 55:31–38PubMed de Groot K, Gross WL, Herlyn K, Reinhold-Keller E (2001) Development and validation of a disease extent index for Wegener’s granulomatosis. Clin Nephrol 55:31–38PubMed
24.
go back to reference Miszalski-Jamka T, Klimeczek P, Tomala M, Krupiński M, Zawadowski G, Noelting J, Lada M, Sip K, Banyś R, Mazur W, Kereiakes DJ, Zmudka K, Pasowicz M (2010) Extent of RV dysfunction and myocardial infarction assessed by CMR are independent outcome predictors early after STEMI treated with primary angioplasty. JACC Cardiovasc Imag 12:1237–1246CrossRef Miszalski-Jamka T, Klimeczek P, Tomala M, Krupiński M, Zawadowski G, Noelting J, Lada M, Sip K, Banyś R, Mazur W, Kereiakes DJ, Zmudka K, Pasowicz M (2010) Extent of RV dysfunction and myocardial infarction assessed by CMR are independent outcome predictors early after STEMI treated with primary angioplasty. JACC Cardiovasc Imag 12:1237–1246CrossRef
25.
go back to reference Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Abdel-Aty H, Gutberlet M, Prasad S, Aletras A, Laissy JP, Paterson I, Filipchuk NG, Kumar A, Pauschinger M, Liu P (2009) International consensus group on cardiovascular magnetic resonance in myocarditis. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol 53:1475–1487PubMedCrossRef Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Abdel-Aty H, Gutberlet M, Prasad S, Aletras A, Laissy JP, Paterson I, Filipchuk NG, Kumar A, Pauschinger M, Liu P (2009) International consensus group on cardiovascular magnetic resonance in myocarditis. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol 53:1475–1487PubMedCrossRef
26.
go back to reference Morton G, Schuster A, Jogiya R, Kutty S, Beerbaum P, Nagel E (2012) Inter-study reproducibility of cardiovascular magnetic resonance myocardial feature tracking. J Cardiovasc Magn Reson 21:14–43 Morton G, Schuster A, Jogiya R, Kutty S, Beerbaum P, Nagel E (2012) Inter-study reproducibility of cardiovascular magnetic resonance myocardial feature tracking. J Cardiovasc Magn Reson 21:14–43
27.
go back to reference Schuster A, Kutty S, Padiyath A, Parish V, Gribben P, Danford DA, Makowski MR, Bigalke B, Beerbaum P, Nagel E (2011) Cardiovascular magnetic resonance myocardial feature tracking detects quantitative wall motion during dobutamine stress. J Cardiovasc Magn Reson 12:13–58 Schuster A, Kutty S, Padiyath A, Parish V, Gribben P, Danford DA, Makowski MR, Bigalke B, Beerbaum P, Nagel E (2011) Cardiovascular magnetic resonance myocardial feature tracking detects quantitative wall motion during dobutamine stress. J Cardiovasc Magn Reson 12:13–58
28.
go back to reference Oshinski JN, Delfino JG, Sharma P, Gharib AM, Pettigrew RI (2000) Cardiovascular magnetic resonance at 3.0 T: current state of the art. J Cardiovasc Magn Reson 7:12–55 Oshinski JN, Delfino JG, Sharma P, Gharib AM, Pettigrew RI (2000) Cardiovascular magnetic resonance at 3.0 T: current state of the art. J Cardiovasc Magn Reson 7:12–55
29.
go back to reference Greenbaum RA, Ho SY, Gibson DG, Becker AE, Anderson RH (1981) Left ventricular fibre architecture in man. Br Heart J 45:248–263PubMedCrossRef Greenbaum RA, Ho SY, Gibson DG, Becker AE, Anderson RH (1981) Left ventricular fibre architecture in man. Br Heart J 45:248–263PubMedCrossRef
30.
go back to reference Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Vogelsberg H, Fritz P, Dippon J, Bock CT, Klingel K, Kandolf R, Sechtem U (2006) Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114:1581–1590PubMedCrossRef Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Vogelsberg H, Fritz P, Dippon J, Bock CT, Klingel K, Kandolf R, Sechtem U (2006) Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114:1581–1590PubMedCrossRef
Metadata
Title
Standard and feature tracking magnetic resonance evidence of myocardial involvement in Churg–Strauss syndrome and granulomatosis with polyangiitis (Wegener’s) in patients with normal electrocardiograms and transthoracic echocardiography
Authors
Tomasz Miszalski-Jamka
Wojciech Szczeklik
Barbara Sokołowska
Krzysztof Karwat
Katarzyna Belzak
Wojciech Mazur
Dean J. Kereiakes
Jacek Musiał
Publication date
01-04-2013
Publisher
Springer Netherlands
Published in
The International Journal of Cardiovascular Imaging / Issue 4/2013
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-012-0158-6

Other articles of this Issue 4/2013

The International Journal of Cardiovascular Imaging 4/2013 Go to the issue